Company intelligence / Profile preview

Kwambio

Odesa, Ukraine

Ownership: Private
Development stage: Other

Overview

Kwambio developed biomaterials and 3D bioprinting technology for organic bone structures under the ADAM project, with materials tested in Sweden and undergoing pre-clinical trials in Ukraine as of 2019. The project faced financial issues leading to cancellation by 2021.

Industry: Implantable Medical Devices

Partnerships

WeFund VenturesApplied MedicalTechstarsStanley Black & DeckerGeneral ElectricAirbus

Beyond the preview

Go deeper on Kwambio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kwambio.

Explore the full profile